USPTO Allows Regulus Stanford Patent Application Covering miR-181a Function In Immune Cells
Regulus said that the patent is owned by Stanford University and licensed exclusively to the company. miR-181a has been shown to regulate the response of immune cells, such
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.